Nissan North America, Inc.
Summary
NHTSA campaign 22V244: Nissan North America, Inc. recalled for a safety defect. An improperly aimed headlight may reduce the driver's visibility, increasing the risk of a crash.
Details
Source
nhtsa
External ID
22V244
Action Date
2022-04-14
Status
Ongoing
Category
vehicle
Product Description
Nissan North America, Inc. (Nissan) is recalling certain 2020 Sentra vehicles, equipped with LED headlights. The right-hand headlight aim may be misaligned. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 108, "Lamp, Reflective Devices, and Associated Equipment."
Company
Context & Analysis
Nissan North America, Inc. has 85 FDA actions in our database.
Frequently Asked Questions
How often does Nissan North America, Inc. have FDA actions?
Nissan North America, Inc. has 85 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle